RHG01_HUMAN - dbPTM
RHG01_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID RHG01_HUMAN
UniProt AC Q07960
Protein Name Rho GTPase-activating protein 1
Gene Name ARHGAP1
Organism Homo sapiens (Human).
Sequence Length 439
Subcellular Localization Cytoplasm.
Protein Description GTPase activator for the Rho, Rac and Cdc42 proteins, converting them to the putatively inactive GDP-bound state. Cdc42 seems to be the preferred substrate..
Protein Sequence MDPLSELQDDLTLDDTSEALNQLKLASIDEKNWPSDEMPDFPKSDDSKSSSPELVTHLKWDDPYYDIARHQIVEVAGDDKYGRKIIVFSACRMPPSHQLDHSKLLGYLKHTLDQYVESDYTLLYLHHGLTSDNKPSLSWLRDAYREFDRKYKKNIKALYIVHPTMFIKTLLILFKPLISFKFGQKIFYVNYLSELSEHVKLEQLGIPRQVLKYDDFLKSTQKSPATAPKPMPPRPPLPNQQFGVSLQHLQEKNPEQEPIPIVLRETVAYLQAHALTTEGIFRRSANTQVVREVQQKYNMGLPVDFDQYNELHLPAVILKTFLRELPEPLLTFDLYPHVVGFLNIDESQRVPATLQVLQTLPEENYQVLRFLTAFLVQISAHSDQNKMTNTNLAVVFGPNLLWAKDAAITLKAINPINTFTKFLLDHQGELFPSPDPSGL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MDPLSELQ
-------CCHHHHHC
12.3522223895
5Phosphorylation---MDPLSELQDDLT
---CCHHHHHCCCCC
41.4720873877
12PhosphorylationSELQDDLTLDDTSEA
HHHCCCCCCCCHHHH
34.8328348404
16PhosphorylationDDLTLDDTSEALNQL
CCCCCCCHHHHHHHH
28.2922199227
17PhosphorylationDLTLDDTSEALNQLK
CCCCCCHHHHHHHHH
28.0622199227
27PhosphorylationLNQLKLASIDEKNWP
HHHHHHHCCCCCCCC
40.8029255136
31UbiquitinationKLASIDEKNWPSDEM
HHHCCCCCCCCCCCC
61.6429967540
35PhosphorylationIDEKNWPSDEMPDFP
CCCCCCCCCCCCCCC
37.5122199227
43UbiquitinationDEMPDFPKSDDSKSS
CCCCCCCCCCCCCCC
67.5222817900
44PhosphorylationEMPDFPKSDDSKSSS
CCCCCCCCCCCCCCC
47.0623927012
47PhosphorylationDFPKSDDSKSSSPEL
CCCCCCCCCCCCHHH
39.1525159151
48UbiquitinationFPKSDDSKSSSPELV
CCCCCCCCCCCHHHH
62.4421906983
49PhosphorylationPKSDDSKSSSPELVT
CCCCCCCCCCHHHHH
39.7529255136
50PhosphorylationKSDDSKSSSPELVTH
CCCCCCCCCHHHHHH
54.3629255136
51PhosphorylationSDDSKSSSPELVTHL
CCCCCCCCHHHHHHC
29.5029255136
56PhosphorylationSSSPELVTHLKWDDP
CCCHHHHHHCCCCCC
33.8323927012
56O-linked_GlycosylationSSSPELVTHLKWDDP
CCCHHHHHHCCCCCC
33.83OGP
59UbiquitinationPELVTHLKWDDPYYD
HHHHHHCCCCCCCHH
40.7629967540
64PhosphorylationHLKWDDPYYDIARHQ
HCCCCCCCHHHHHHH
22.2928152594
65PhosphorylationLKWDDPYYDIARHQI
CCCCCCCHHHHHHHE
13.2728152594
80UbiquitinationVEVAGDDKYGRKIIV
EEECCCCCCCCEEEE
55.1122817900
80AcetylationVEVAGDDKYGRKIIV
EEECCCCCCCCEEEE
55.1119608861
802-HydroxyisobutyrylationVEVAGDDKYGRKIIV
EEECCCCCCCCEEEE
55.11-
81PhosphorylationEVAGDDKYGRKIIVF
EECCCCCCCCEEEEE
29.20-
84UbiquitinationGDDKYGRKIIVFSAC
CCCCCCCEEEEEEEC
32.2122817900
89PhosphorylationGRKIIVFSACRMPPS
CCEEEEEEECCCCCH
18.6328857561
93SulfoxidationIVFSACRMPPSHQLD
EEEEECCCCCHHHCC
6.0230846556
144PhosphorylationLSWLRDAYREFDRKY
HHHHHHHHHHHHHHH
18.24-
156UbiquitinationRKYKKNIKALYIVHP
HHHHHHCCEEEECCH
41.5533845483
159PhosphorylationKKNIKALYIVHPTMF
HHHCCEEEECCHHHH
13.03-
168UbiquitinationVHPTMFIKTLLILFK
CCHHHHHHHHHHHHH
23.1221890473
169PhosphorylationHPTMFIKTLLILFKP
CHHHHHHHHHHHHHH
23.2120068231
174UbiquitinationIKTLLILFKPLISFK
HHHHHHHHHHHHHHC
6.4123000965
175UbiquitinationKTLLILFKPLISFKF
HHHHHHHHHHHHHCC
35.1533845483
178UbiquitinationLILFKPLISFKFGQK
HHHHHHHHHHCCCCE
6.5422817900
179PhosphorylationILFKPLISFKFGQKI
HHHHHHHHHCCCCEE
30.0224719451
212UbiquitinationGIPRQVLKYDDFLKS
CCCHHHHCHHHHHHH
48.0223000965
212AcetylationGIPRQVLKYDDFLKS
CCCHHHHCHHHHHHH
48.0223236377
218MethylationLKYDDFLKSTQKSPA
HCHHHHHHHCCCCCC
51.99-
218UbiquitinationLKYDDFLKSTQKSPA
HCHHHHHHHCCCCCC
51.9923000965
219PhosphorylationKYDDFLKSTQKSPAT
CHHHHHHHCCCCCCC
37.9126699800
220PhosphorylationYDDFLKSTQKSPATA
HHHHHHHCCCCCCCC
38.1326699800
222UbiquitinationDFLKSTQKSPATAPK
HHHHHCCCCCCCCCC
59.5033845483
223PhosphorylationFLKSTQKSPATAPKP
HHHHCCCCCCCCCCC
15.2226055452
226PhosphorylationSTQKSPATAPKPMPP
HCCCCCCCCCCCCCC
47.0430576142
245PhosphorylationPNQQFGVSLQHLQEK
CCCCCCCCHHHHHHH
23.7722115753
284PhosphorylationTEGIFRRSANTQVVR
CCCCHHHCCCHHHHH
22.9328857561
299SulfoxidationEVQQKYNMGLPVDFD
HHHHHHCCCCCCCHH
5.4630846556
365PhosphorylationQTLPEENYQVLRFLT
HHCCHHHHHHHHHHH
11.86-
379PhosphorylationTAFLVQISAHSDQNK
HHHHHHHHHCCCCCC
11.6622210691
382PhosphorylationLVQISAHSDQNKMTN
HHHHHHCCCCCCCCC
40.3822210691
388PhosphorylationHSDQNKMTNTNLAVV
CCCCCCCCCCCEEEE
40.2722210691
390PhosphorylationDQNKMTNTNLAVVFG
CCCCCCCCCEEEEEC
23.5724505115
409PhosphorylationWAKDAAITLKAINPI
CHHCHHHHHHHCCCC
19.9222210691
411UbiquitinationKDAAITLKAINPINT
HCHHHHHHHCCCCHH
38.2732015554
420PhosphorylationINPINTFTKFLLDHQ
CCCCHHHHHHHHHCC
20.8824505115
433PhosphorylationHQGELFPSPDPSGL-
CCCCCCCCCCCCCC-
34.3024076635
437PhosphorylationLFPSPDPSGL-----
CCCCCCCCCC-----
61.1727251275

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of RHG01_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of RHG01_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of RHG01_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RHG01_HUMANARHGAP1physical
10954711
BNIP2_HUMANBNIP2physical
10954711
RHOA_HUMANRHOAphysical
9548756
RHOA_HUMANRHOAphysical
9407060
CDC42_HUMANCDC42physical
9407060
BNIP2_HUMANBNIP2physical
10551883
RAC1_HUMANRAC1physical
9535855
CDC42_HUMANCDC42physical
9535855
RHOA_HUMANRHOAphysical
9535855
RHOA_HUMANRHOAphysical
20660160
CHK2_HUMANCHEK2physical
21988832
GFPT1_HUMANGFPT1physical
26344197
RUVB2_HUMANRUVBL2physical
26344197
CDC42_HUMANCDC42physical
14749388
RAC1_HUMANRAC1physical
14749388
RHOA_HUMANRHOAphysical
14749388
ATRAP_HUMANAGTRAPphysical
21516116

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of RHG01_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-80 AND LYS-212, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51, AND MASSSPECTROMETRY.
"Phosphoproteome of resting human platelets.";
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.;
J. Proteome Res. 7:526-534(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51, AND MASSSPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51, AND MASSSPECTROMETRY.

TOP